INTELLIGENCE BRIEFINGS
The intelligence briefings your AI validation layer produces before you need to explain the decision.
Editorial analysis, regulatory alerts, clinical trial movement, and cross-entity intelligence — adversarially validated and curated for biopharmaceutical decision-makers.
Editorial Briefings CURATED ANALYSIS
Clinical Trials 200 ACTIVE SIGNALS
CLINICALTRIALS.GOV / NIH
200 Phase II/III signals tracked on a scheduled refresh
FDA Recalls & Alerts 69 ACTIVE SIGNALS
U.S. FOOD & DRUG ADMINISTRATION
69 enforcement actions and recall alerts monitored
EMA Safety Alerts EUROPEAN MEDICINES AGENCY
EUROPEAN MEDICINES AGENCY
EU regulatory decisions and CHMP opinions tracked on a scheduled refresh
PubMed Research 150 ACTIVE SIGNALS
PUBMED / NCBI BIOMEDICAL LITERATURE
150 peer-reviewed signals indexed and scored
CURRENT VISIBLE FEED
419 signals in the public feed (scheduled refresh, not a live feed).
The /signals feed shows the public-tier stream. Platform capacity spans a large corpus of regulatory signals indexed across 13 source streams (see /press). The public number is the visible feed, not the total processed.
▸ Launch-tier directional metric · updates as platform matures
Open Signals Feed →